GOLDMAN SACHS GROUP INC - 30 Jun 2025 SCHEDULE 13G Report for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (SWTX)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
SWTX
Shares outstanding
75,607,738 shares
Disclosed Ownership
4,234,033 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
13 Aug 2025, 17:25:40 UTC
Date of event
30 Jun 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GOLDMAN SACHS GROUP INC disclosed 5.6% ownership in SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (SWTX) on 30 Jun 2025."

Quick Takeaways

  • GOLDMAN SACHS GROUP INC filed SCHEDULE 13G for SPRINGWORKS THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (SWTX).
  • Disclosed ownership: 5.6%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Aug 2025, 17:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 5.6% 4,234,033 0 4,233,899 Name: Sam Prashanth Attorney-in-fact
GOLDMAN SACHS & CO. LLC 5.6% 4,234,033 0 4,233,899 Name: Sam Prashanth Attorney-in-fact

Sponsored